 6.jpg)
Indian telemedicine apps in 2026, from government-backed eSanjeevani to AI-powered platforms like mFine, that are collectively dismantling the urban-rural healthcare divide through technology, scale, and on-demand care.
Zydus Worldwide DMCC, a subsidiary of Zydus Lifesciences, has signed a deal with Assertio Holdings, Inc., through its wholly-owned subsidiary, Zara Merger Sub Inc., marking its entry into the US Oncology market.
India’s pharmaceutical export sector is set to benefit from a new cold-chain rail service launched between Hyderabad and Mumbai, a move expected to improve the transportation of temperature-sensitive medicines and strengthen the country’s expor...
Every year on May 12, the world celebrates International Nurses Day to recognize the extraordinary contribution of nurses in healthcare systems worldwide. The day marks the birth anniversary of Florence Nightingale, the founder of modern nursing...
A new one-time cell therapy, for HIV infection has shown promising results in a small early-stage study, raising hopes for a future where people living with HIV may not need lifelong daily medication. Researchers found that the experiment...
India’s pharmaceutical sector witnessed major regulatory changes between May 4 and May 9 as the Central Drugs Standard Control Organisation (CDSCO) rolled out stricter compliance measures and accelerated approval reforms.
For decades, India’s role in pharma research was restricted to the role of a cost-effective destination for late-stage clinical trials. But now with Novartis, India will become the next pharma research capital.
Lupin Q4 profit, US sales growth, and strong revenue momentum remained in focus after the pharmaceutical company reported an 87.7% jump in consolidated net profit to Rs 1,468.7 crore for the fourth quarter of FY2026. The impressive performan...
Capital Utilisation and Profitability have become the key focus areas for Biocon as the company moves beyond its aggressive expansion phase and shifts attention toward improving margins and operational efficiency.
Dr Reddy’s and Nestlé Health Science have strengthened their presence in India’s growing obesity nutrition care market with the launch of Celevida GLP+, a nutrition supplement designed for people using GLP-1 and GIP-based therapies for obesity...
.jpg)
, CDSCO.jpg)